Detalles de la búsqueda
1.
CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy.
BMC Cancer
; 19(1): 1173, 2019 Dec 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31795962
Resultados
1 -
1
de 1
1
Próxima >
>>